Related Experiment Videos
Infectious morbidity in gynecologic cancer
American Journal of Obstetrics and Gynecology
|February 1, 1987
Summary
Serious infections complicate gynecologic oncology care, affecting 11% of patients and 6% of admissions. Vulvar and cervical cancer patients faced the highest infection rates, highlighting risks from treatment and tumor factors.
Area of Science:
- Gynecologic Oncology
- Infectious Diseases
- Oncology
Background:
- Infectious morbidity is a significant concern in gynecologic oncology.
- Understanding infection rates and risk factors is crucial for patient management.
Observation:
- A retrospective study analyzed 494 patients and 1204 admissions.
- Serious infections complicated 11% of patients and 6% of admissions.
- Highest infection rates were observed in vulvar (21% of admissions) and cervical cancer (22% surgical morbidity) patients.
Findings:
- Key risk factors for infection include host factors, radical surgery, tumor characteristics, and adjuvant therapies (irradiation, chemotherapy).
- Polymicrobial infections are common, necessitating careful antimicrobial selection and monitoring.
- Observed complications include beta-lactamase induction, superinfection, nephrotoxicity, and necrotizing enterocolitis.
Implications:
- Optimizing antimicrobial strategies and vigilant monitoring are essential to mitigate serious infections and their complications in gynecologic oncology.
- Further research into preventative measures and targeted therapies is warranted.